Literature DB >> 23474364

Chemoradiotherapy for locally advanced pancreatic cancer.

Markus K Diener, Stephanie E Combs, Markus W Büchler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23474364     DOI: 10.1016/S1470-2045(13)70091-3

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  6 in total

1.  [Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP)].

Authors:  S B Harrabi; M W Büchler; J Werner; S E Combs
Journal:  Strahlenther Onkol       Date:  2014-03       Impact factor: 3.621

2.  Expression and clinical significance of glucose transporter-1 in pancreatic cancer.

Authors:  Kai Lu; Jian Yang; DE-Chun Li; Song-Bing He; Dong-Ming Zhu; Li-Feng Zhang; X U Zhang; Xiao-Chen Chen; Bing Zhang; Jian Zhou
Journal:  Oncol Lett       Date:  2016-05-16       Impact factor: 2.967

3.  Phase I study of capecitabine combined with radioembolization using yttrium-90 resin microspheres (SIR-Spheres) in patients with advanced cancer.

Authors:  S J Cohen; A A Konski; S Putnam; D S Ball; J E Meyer; J Q Yu; I Astsaturov; C Marlow; A Dickens; D N Cade; N J Meropol
Journal:  Br J Cancer       Date:  2014-07-01       Impact factor: 7.640

4.  HNRNPA2B1 regulates the epithelial-mesenchymal transition in pancreatic cancer cells through the ERK/snail signalling pathway.

Authors:  Shengjie Dai; Bicheng Chen; Mengtao Zhou; Jie Zhang; Shihao Huang; Bin Lou; Binbo Fang; Tingting Ye; Xince Huang
Journal:  Cancer Cell Int       Date:  2017-01-10       Impact factor: 5.722

5.  Wogonin induces Beclin-1/PI3K and reactive oxygen species-mediated autophagy in human pancreatic cancer cells.

Authors:  Shao-Jun Li; Shi-Jie Sun; Jie Gao; Fu-Bo Sun
Journal:  Oncol Lett       Date:  2016-11-08       Impact factor: 2.967

6.  Astaxanthin inhibits gemcitabine-resistant human pancreatic cancer progression through EMT inhibition and gemcitabine resensitization.

Authors:  Tao Yan; Hai-Ying Li; Jian-Song Wu; Qiang Niu; Wei-Hong Duan; Qing-Zeng Han; Wang-Ming Ji; Tao Zhang; Wei Lv
Journal:  Oncol Lett       Date:  2017-08-28       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.